Observation of ImageReady™ MR Conditional Pacing System in China
- Conditions
- Atrioventricular Heart-blockArhythmiaChronic Bundle Branch or Branch BlockCarotid Sinus Hypersensitivity Reaction SyndromeVasovagal Syncope
- Interventions
- Device: ImageReady™ MR Conditional Pacing System
- Registration Number
- NCT02636712
- Lead Sponsor
- Boston Scientific Corporation
- Brief Summary
To observe the safety and efficacy of ImageReady™ MR Conditional Pacing System in Chinese subjects
- Detailed Description
Key Inclusion Criteria:
1. Subject must have the Image Ready System as their initial (de novo) pacing system implant.
2. Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines.
3. Subject is able and willing to undergo an MR scan.•
4. Subject is willing and capable of providing informed consent and participating in all testing/ visits associated with this clinical study at the intervals defined by this protocol.
5. Subject is age 18 or above.
Key Exclusion Criteria
1. Subject has or has had any pacing or ICD system implants.
2. Subject has any implants or devices that are not suitable for MR scan.
3. Subject is enrolled in any other concurrent study that might interfere with this study.
4. Subject has documented life expectancy of less than 12 months.
5. Women of childbearing potential who are or might be pregnant at the time of this study.
Primary Safety Endpoint:
MR Scan related Complication Free Rate Analyzed at MRI Visit +1 Month.
Primary efficacy Endpoint:
1. Pacing Threshold (at 0.5 ms pulse width) comparison pre and 1 Month post MR Scan: pacing threshold increase ≤ 0.5 V after scan.
2. Sensed Amplitude comparison pre- and 1 Month post-MR Scan: sensed amplitude: ≥ 1.0 mV after scan, and ≥ 50% of that before scan.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
- Subject must have the ImageReady System as their initial (de novo) pacing system implant
- Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines5
- Subject is able and willing to undergo an MR scan
- Subject is willing and capable of providing informed consent and participating in all testing/ visits associated with this clinical study at the intervals defined by this protocol
- Subject is age 18 or above
- Subject has or has had any pacing or ICD system implants
- Subject has any implants or devices that are not suitable for MR scan
- Subject is enrolled in any other concurrent study that might interfere with this study
- Subject has documented life expectancy of less than 12 months
- Women of childbearing potential who are or might be pregnant at the time of this study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description ImageReady™ MR Conditional Pacing System ImageReady™ MR Conditional Pacing System 1. Subject must have the ImageReady™ System as their initial (de novo) pacing system implant 2. Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines
- Primary Outcome Measures
Name Time Method Percentage of Participants Without Complications at MRI Visit + 1 Month. Within 1 month after the Pacemaker been implanted. No one has any complications related MR Scan . So Complication-Free rate is 100%.
Percentage of Participants With Atrial Sensed Amplitude at the MRI Visit + 1 Month Follow up Remains ≥ 1.0 mV and Above 50% of the Pre-MR Scan Value Pre-MR scan and 1 Month post-MR Scan. The Percentage of participants with atrial sensed amplitude at the MRI Visit + 1 Month Follow up remains ≥ 1.0 mV and above 50% of the pre-MR scan value is 100%.
Percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) From Pre-MR Scan to MRI Visit + 1 Month Follow-up Pre-MR scan and 1 Month post-MR Scan. The percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) from Pre-MR Scan to MRI Visit + 1 Month Follow-up is 100 percent.
Percentage of Participants With Ventricular Sensed Amplitudes at the MRI Visit + 1 Month Follow up Remains ≥ 5.0 mV and Above 50% of the Pre-MR Scan. Pre-MR scan and 1 Month post-MR Scan. The percentage of participants with ventricular sensed amplitudes at the MRI Visit + 1 Month Follow up remains ≥ 5.0 mV and above 50% of the pre-MR scan is 100%.
- Secondary Outcome Measures
Name Time Method Percentage of Participants Without System-related Complications Within 3 months after the Pacemaker been implanted. No one has any complications related system occurred. So Complication-Free rate is 100%.
Trial Locations
- Locations (2)
Shanghai Zhongshan Hospital
🇨🇳Shanghai, Shanghai, China
Jiangsu Province Hospital
🇨🇳Nanjing, Jiangsu, China